AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2016
May 12, 2016
29755_dirs_2016-05-12_d2535f3a-943e-4daa-92a0-e9a02d42d711.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-05-10
Reporting Person: HURWICH THOMAS A. (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-10 | Common stock, $0.01 par value | M | 6000 | $27.29 | Acquired | 68204 | Direct |
| 2016-05-10 | Common stock, $0.01 par value | S | 5900 | $63.59 | Disposed | 62304 | Direct |
| 2016-05-10 | Common stock, $0.01 par value | S | 100 | $63.60 | Disposed | 62204 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-10 | Option (right to buy) | $27.29 | M | 6000 | Disposed | 2017-02-15 | Common shares (6000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 430 | Indirect |
| Common stock, $0.01 par value | 274 | Indirect |
Footnotes
F1: Balance in the AbbVie Savings Program as of May 10, 2016.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4